Philip J. Aliotta

Efficacy and Safety of OnabotulinumtoxinA in Patients with Urinary Incontinence Due to Neurogenic Detrusor Overactivity: A Randomised, Double-Blind, Placebo-Controlled Trial

Francisco Cruz, Sender Herschorn, Philip J. Aliotta et al. · European Urology · 2011 · 467 citations

Urology, Voiding Dysfunction, Female Urology +6

Tadalafil dosed once a day in men with erectile dysfunction: a randomized, double-blind, placebo-controlled study in the US

Jacob Rajfer, Philip J. Aliotta, Christopher P. Steidle et al. · International Journal of Impotence Research · 2006 · 115 citations

Urology, Erectile Dysfunction, Pharmacology +5

OnabotulinumtoxinA is Effective in Patients with Urinary Incontinence due to Neurogenic Detrusor Activity Regardless of Concomitant Anticholinergic Use or Neurologic Etiology

David A. Ginsberg, Francisco Cruz, Sender Herschorn et al. · Advances in Therapy · 2013 · 81 citations · Full text

Erectile response with vardenafil in sildenafil nonresponders: a multicentre, double‐blind, 12‐week, flexible‐dose, placebo‐controlled erectile dysfunction clinical trial

Culley C. Carson, Dimitrios Hatzichristou, Serge Carrier et al. · British Journal of Urology · 2004 · 69 citations

Primary mediastinal germ cell tumors histologic patterns of treatment failures at autopsy

Philip J. Aliotta, Javier Castillo, Lenore S. Englander et al. · Cancer · 1988 · 41 citations · Full text

Surgical Oncology, Treatment Failures, Pathology +17